The Food and Drug Administration in the States has approved Avanafil for market and it will be branded as Stendra .The drug is expected to join the 4 billion dollar global erectile dysfunction treatment market by 2013 after the drug manufacturers have made decisions regarding the packaging and distribution of the drug.
As we have explained before, Stendra will have an advantage over its competitors in that it begins to work within 30 minutes and has been reported to work after only 15 minutes in some patients. Other PDE5 inhibitors are known to take around 1 hour to get working in certain cases.
The pharmaceutical company also applied to the European Medicines Agency (EMA) on March 26th of this year and a Marketing Authorization Application was accepted by the European regulators. We will update our pages with the latest news on the approval of Avanafil in Europe as soon as we have it but we expect Avanafil to be approved in the EU before the end of 2012.